National Society Sessions

​​Following the success of the previous ESGO National Society track in 2013, ESGO has selected 6 national societies to present their exciting programmes during the 2015 scientific programme. In addition, there will be 4 sessions presented by SFOG.


ARBEITSGEMEINSCHAFT GYNAEKOLOGISHE ONKOLOGIE E.V. (AGO) AND NORTH-EASTERN SOCIETY FOR GYNECOLOGICAL ONCOLOGY (NOGGO) JOINT SESSION

Controversies in Gynecological Oncology

Coordinators: ​Jalid Sehouli (Germany)
                      Tanja Fehm (Germany)

  • Cervical Cancer​ – Fertility Preservation 
    • Radical Trachelektomy
      Ingo Runnebaum (Germany)
    • Neoadjuvant chemotherapy
      Frederic Amant (Belgium)​
  • ​Ovarian Cancer
    • Neoadjuvant primary surgery in advanced ovarian cancer - Pro/Con
      Ignace Vergote (Belgium) / Jalid Sehouli (Germany)
  • Endometrial Cancer​
    • Antihormonal therapy in advanced and relapsed endometrial cancer - Pro/ Con
      ​Günter​ Emons (Germany) Stefano Greggi (Italy)


BRITISH GYNAECOLOGICAL CANCER SOCIETY

Ovarian Cancer Research Update: From The Laboratory To The Clinic To The Operating Theatre​

Coordina
tors: Raj Naik (United Kingdom) 
                      Charlie Gourley (United Kingdom)

  • Genetic and molecular changes in ovarian cancer​
    Charlie Gourley (United Kingdom)
  • ​OPCML: systems regulation of receptor kinase networks in ovarian cancer​
    Hani Gabra (United Kingdom)
  • Surgical Bioengineering and tumour heterogeneity
    Christina Fotopoulou (United Kingdom)
  • Update on a phase 1b trial of pazopanib plus fosbretablin​
    Gordon Rustin (United Kingdom)
  • ​TOPCAT: A surgical trial of ultra-radical surgery in advanced ovarian cancer
    Raj Naik (United Kingdom)


FRENCH SOCIETY OF GYNAECOLOGICAL CANCER (SFOG)

SFOG 1: Parallel Session: Sentinel Node

Coordinators: Patrice Mathevet (France)
                      Fabrice Lécuru (France)​

• New techniques for sentinel node identification: Fluorophore, magnetic marker...                 Detection rate and false negative cases. 
        Fabrice Lécuru (France) 
• Cervical cancer and SN technique: SN alone or in association with pelvic lymph-node         dissection? 
        Patrice Mathevet (France) 
• Vulvar cancer and SN technique: What are the false negative cases, what are the               valid indications for the SN technique? 
        Ate GJ van der Zee (The Netherlands) 
• Endometrial cancer and SN technique: what are the indications and the principal                technical aspects? 
       Nadeem R. Abu-Rustum (USA)

SFOG 2: Free Communications In French​​

Speakers: Florence Letinier (France)
                 Sébastien Gouy (France)

SFOG 3: Free Communications In English

Coordinators: Philippe Morice (France)
                      Catherine Genestie (France)

SFOG 4: Free Communications In English​

Speakers: Yves Aubard​ (France)
                 Anne Floquet​ (France)

ISRAELI SOCIETY OF GYNECOLOGIC ONCOLOGY (ISGO)

Hereditary Ovarian cancer: Screening options, surgical interventions and post-operative treatment​

Coordinators: A. Fishman (Israel)
                      J. Korach (Israel)

  • Overview of ovarian cancer in relation to BRCA mutation carriers​
    Tally Levy (Israel)
  • Screening recommendations: High-risk population only? General population?
    Ilan Bruchim (Israel)​
  • Is there place for PGD in mutation carriers?
    Uzi Beller (Israel)
  • Should salpingectomy precede oophorectomy?​
    Mario Beiner (Israel)
  • ​Should hysterectomy be considered?
    Ofer Lavie (Israel)
  • Post-operative HRT – pros & cons​
    Ofer Gemer (Israel)
  • ​Role of PARP inhibitors and future directions
    Ora Rosengarten (Israel)


NORDIC SOCIETY OF GYNAECOLOGIC ONCOLOGY (NSGO)

Recent Advances in the Management of Gynaecological Malignancies

Coordinators: Elisabeth Åvall-Lundqvist (Sweden)
                      Mansoor Raza Mirza (Denmark)

  • Role of anti-agiogenic therapy in gynecological malignancies
    Johanna Mäenpää (Finland)
  • ​PARP inhibitors in ovarian cancer
    Elisabeth Åvall-Lundqvist (Sweden)
  • Hormonal clinical applications of genomic research in endometrial cancer​
    Helga B. Salvesen (Norway)  
  • Role of chemotherapy in endometrial cancer
    Mansoor Raza Mirza (Denmark)
  • ​Discussion


SPANISH SOCIETY OF GYNAECOLOGIC ONCOLOGY AND OBSTETRICS (SEGO)

Sentinel node - Spanish Guidelines (Oncoguias SEGO) and video-technique

Coordinators: Jordi Ponce (Spain)​
                      Maite Cusidó (Spain)​

  • Introducing the state of the art
    ​Ricardo Sainz de la Cuesta (Spain)
  • Vulvar cancer: Can we avoid lymphadenectomy?
    Santiago Domingo (Spain)
  • Cervical cancer: Only for frozen section study?
    Javier de Santiago (Spain)
  • Endometrial cancer: In which cases is it indicated?
    Mikel Gorostidi (Spain)
  • Breast cancer: In which cases can we do without?
    Elena Alvarez​ ​(Spain)
  • Open discussion​
    Moderation: Jordi Ponce (Spain)


​TURKISH SOCIETY OF GYNECOLOGIC ONCOLOGY

Surgical techniques video session

Coordinators: Sabit Sinan Ozalp (Turkey) 
               ​       K. Yuce (Turkey)

  • Splenectomy and distal pancreatectomy
    Ali Ayhan (Turkey)
  • Hepatoduedenal ligament and celiac plexus exploration and tumor resection
    Haldun Guner, Anil Onan, Cagatay Taskiran (Turkey)
  • Total omentectomy
    Gokhan Tulunay, Nurettin Boran (Turkey)
  • Peritonectomy
    Kunter Yuce, Nejat Özgül, Coskun Salman (Turkey)
  • ​Rectosigmoid resection and anastomosis
    U. Firat Ortac (Turkey)
  • Pelvic exentration
    Macit Arvas, Fuat Demirkıran, Tugan Bese (Turkey)
  • ​Laparoscopic pelvic and paraaortic lymphadenectomy
    Aytekin Altintas, M. Ali Vardar (Turkey)
  • Robotic pelvic and paraaortic lymphadenectomy
    M. Faruk Kose, M. Murat Naki (Turkey)
  • Robotic extraperitoneal paraaortic lymphadenectomy
    Mufit C. Yenen, Murat Dede (Turkey)
  • ​Robotic radical trachelectomy​
    Ilkkan Dunder, Mete Gungor (Turkey)​​
  • Laparoscopic sigmoid interposition​
    Ates Karateke (Turkey)​
  • Discussion
​​

Keep Me Updated